Skip to content
Screener

SG&A at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.91B
Danaher logo
DanaherDHR
$2.07B-12.2%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$676.2M+69.5%
WAT
Waters CorporationWAT
$405M+101%
Agilent Technologies logo
Agilent TechnologiesA
$465M+2.4%
Illumina logo
IlluminaILMN
$273M+16.7%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$12.83B+28.7%
Enterprise value$15.91B+28.6%
P/E53.5×+18.6×
P/S4.4×+0.9×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000031791-26-000019
Line itemThree Months Ended / April 5,2026Three Months Ended / March 30,2025
Cost of product revenue273,320250,155
Cost of service revenue50,14339,061
Total cost of revenue323,463289,216
Selling, general and administrative expenses253,882249,719
Research and development expenses57,88753,597
Operating income from continuing operations75,88672,230
Interest and other expense, net25,89419,848
Income from continuing operations before income taxes49,99252,382

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's SG&A?
Revvity (RVTY) reported SG&A of $253.88M in Q1 2026.
How has Revvity's SG&A changed year-over-year?
Revvity's SG&A increased by 1.7% year-over-year, from $249.72M to $253.88M.
What is the long-term trend for Revvity's SG&A?
Over 4 years (2021 to 2025), Revvity's SG&A has grown at a -2.6% compound annual growth rate (CAGR), from $1.1B to $991.89M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Ask your AI about Revvity's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude